By performing deep-proteome analyses of explanted hearts from patients with end-stage ARVC, we previously found that several complement system components, including factors C3, C6, C7, C8, and C9, are significantly upregulated in both ventricles 18. The gene discussed is C9; the disease is arrhythmogenic right ventricular cardiomyopathy.